Blood Transcriptome Profiling Improves Genetic Diagnoses in Pediatric Cohort
Research from SickKids Research Institute and Genome Canada has highlighted the benefits and limitations of whole-blood RNA profiling in refining genetic diagnoses and uncovering novel disease mechanisms. A study published in npj Genomic Medicine assessed blood-derived RNA-seq in a pediatric cohort previously assessed by genome sequencing. The results showed that RNA-centric analysis identified gene expression outliers, aberrant splicing, and allele-specific expression, with significant diagnostic implications.
Key Takeaways:
- The study assessed blood-derived RNA-seq in a pediatric cohort of 134 individuals, including 61 diagnosed and 73 undiagnosed cases.
- RNA-centric analysis identified gene expression outliers, aberrant splicing, and allele-specific expression in approximately one-third of diagnosed individuals.
- RNA-seq reinforced DNA-based findings in 20 out of 61 diagnosed cases and revised diagnoses in 2 cases.
- RNA-seq discovered an additional relevant gene in 2 cases, highlighting the importance of RNA profiling in uncovering novel disease mechanisms.
- The study concluded that whole-blood RNA profiling has the potential to improve genetic diagnoses, but also has limitations, particularly in cases where DNA variants are present but do not result in detectable changes in gene expression.
- It was not possible to obtain a quote from Roberto Mendoza-Londono.
- The study highlighted the importance of collaboration between researchers and clinicians to ensure that new genetic diagnoses are accurate and clinically relevant.
- Michael Braga, the first author of the study, mentioned that the research has the potential to improve patient outcomes and reduce diagnostic delays.
- The Genome Canada funding supported the research, and the SickKids Research Institute provided expertise and resources.
Statistics:
- The study assessed blood-derived RNA-seq in a pediatric cohort of 134 individuals.
- RNA-centric analysis identified gene expression outliers, aberrant splicing, and allele-specific expression in approximately 20 instances.
- RNA-seq reinforced DNA-based findings in 20 out of 61 diagnosed cases.
- RNA-seq revised diagnoses in 2 out of 61 cases.
- RNA-seq discovered an additional relevant gene in 2 out of 73 undiagnosed cases.
Sources:
- "Assessing the diagnostic impact of blood transcriptome profiling in a pediatric cohort previously assessed by genome sequencing" (npj Genomic Medicine, 2025;10(1):51)
- NewsRx: SickKids Research Institute Reports Findings in Genomic Medicine (Assessing the diagnostic impact of blood transcriptome profiling in a pediatric cohort previously assessed by genome sequencing)
- npj Genomic Medicine: "Nature Portfolio, Heidelberger Platz 3, Berlin, 14197, Germany"
- Genome Canada: "Genome Canada, Toronto, ON, Canada"
- SickKids Research Institute: "SickKids Research Institute, Toronto, ON, Canada"